Literature DB >> 22966321

Reduced CD73 expression and its association with altered purine nucleotide metabolism in colorectal cancer cells robustly causing liver metastases.

Masahiro Matsuyama1, Masatoshi Wakui, Makoto Monnai, Tomoko Mizushima, Chiyoko Nishime, Kenji Kawai, Mitsuyo Ohmura, Hiroshi Suemizu, Takako Hishiki, Makoto Suematsu, Mitsuru Murata, Tsuyoshi Chijiwa, Daisuke Furukawa, Kyoji Ogoshi, Hiroyasu Makuuchi, Masato Nakamura.   

Abstract

Liver metastases of colorectal cancers significantly affect the prognoses of patients. To further understand the biological aspects of the metastatic phenotypes, we established the highly liver-metastatic human colorectal cancer cell subline SW48LM2. The subline was established through the serial intrasplenic transfer of cells derived from poor but visible hepatic tumor foci formed by parental SW48 cells and transferred to NOD/SCID/IL-2Rγc(null) mice. The growth, both under monolayer culture conditions and during the formation of subcutaneous tumors, was similar between the two cell lines, although there were morphological differences in the in vitro spheroid formation. Of 41 molecules reportedly associated positively or negatively with tumor progression, four were overexpressed and four were underexpressed in SW48LM2 cells. Notably, this liver-metastatic cell subline exhibited a strongly reduced expression of the ecto-5'-nucleotidase CD73 as well as an altered metabolism of purine nucleotides. Previous studies showed a positive correlation between CD73 expression and metastatic cancer phenotypes. A reduced CD73 expression in tumor cells, however, may contribute to obtaining insight into the mechanisms of liver metastases.

Entities:  

Year:  2010        PMID: 22966321      PMCID: PMC3436221          DOI: 10.3892/ol_00000076

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  20 in total

1.  Adenosine receptor agonists differentially regulate IL-10, TNF-alpha, and nitric oxide production in RAW 264.7 macrophages and in endotoxemic mice.

Authors:  G Haskó; C Szabó; Z H Németh; V Kvetan; S M Pastores; E S Vizi
Journal:  J Immunol       Date:  1996-11-15       Impact factor: 5.422

Review 2.  Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression.

Authors:  Thomas Brabletz; Andreas Jung; Simone Spaderna; Falk Hlubek; Thomas Kirchner
Journal:  Nat Rev Cancer       Date:  2005-09       Impact factor: 60.716

3.  NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells.

Authors:  Mamoru Ito; Hidefumi Hiramatsu; Kimio Kobayashi; Kazutomo Suzue; Mariko Kawahata; Kyoji Hioki; Yoshito Ueyama; Yoshio Koyanagi; Kazuo Sugamura; Kohichiro Tsuji; Toshio Heike; Tatsutoshi Nakahata
Journal:  Blood       Date:  2002-11-01       Impact factor: 22.113

4.  Differential metabolomics reveals ophthalmic acid as an oxidative stress biomarker indicating hepatic glutathione consumption.

Authors:  Tomoyoshi Soga; Richard Baran; Makoto Suematsu; Yuki Ueno; Satsuki Ikeda; Tadayuki Sakurakawa; Yuji Kakazu; Takamasa Ishikawa; Martin Robert; Takaaki Nishioka; Masaru Tomita
Journal:  J Biol Chem       Date:  2006-04-11       Impact factor: 5.157

Review 5.  Treatment of liver metastases, an update on the possibilities and results.

Authors:  T Ruers; R P Bleichrodt
Journal:  Eur J Cancer       Date:  2002-05       Impact factor: 9.162

6.  Effects of ecto-5'-nucleotidase on human breast cancer cell growth in vitro and in vivo.

Authors:  Xuerui Zhou; Xiuling Zhi; Ping Zhou; Sifeng Chen; Fengdi Zhao; Zhimin Shao; Zhouluo Ou; Lianhua Yin
Journal:  Oncol Rep       Date:  2007-06       Impact factor: 3.906

7.  Monocarboxylate transporter 4 regulates maturation and trafficking of CD147 to the plasma membrane in the metastatic breast cancer cell line MDA-MB-231.

Authors:  Shannon M Gallagher; John J Castorino; Dian Wang; Nancy J Philp
Journal:  Cancer Res       Date:  2007-05-01       Impact factor: 12.701

8.  Liver metastasis models of colon cancer for evaluation of drug efficacy using NOD/Shi-scid IL2Rgammanull (NOG) mice.

Authors:  Kenji Hamada; Makoto Monnai; Kenji Kawai; Chiyoko Nishime; Chika Kito; Noriyuki Miyazaki; Yasuyuki Ohnishi; Masato Nakamura; Hiroshi Suemizu
Journal:  Int J Oncol       Date:  2008-01       Impact factor: 5.650

9.  Identification of a key molecular regulator of liver metastasis in human pancreatic carcinoma using a novel quantitative model of metastasis in NOD/SCID/gammacnull (NOG) mice.

Authors:  Hiroshi Suemizu; Makoto Monnai; Yasuyuki Ohnishi; Mamoru Ito; Norikazu Tamaoki; Masato Nakamura
Journal:  Int J Oncol       Date:  2007-10       Impact factor: 5.650

10.  Inhibition of hepatic endothelial E-selectin expression by C-raf antisense oligonucleotides blocks colorectal carcinoma liver metastasis.

Authors:  Abdel-Majid Khatib; Lucia Fallavollita; Edward V Wancewicz; Brett P Monia; Pnina Brodt
Journal:  Cancer Res       Date:  2002-10-01       Impact factor: 12.701

View more
  6 in total

1.  Zinc finger protein 185 is a liver metastasis-associated factor in colon cancer patients.

Authors:  Daisuke Furukawa; Tsuyoshi Chijiwa; Masahiro Matsuyama; Masaya Mukai; Ei-Ichi Matsuo; Osamu Nishimura; Kenji Kawai; Hiroshi Suemizu; Nobuyoshi Hiraoka; Toshio Nakagohri; Seiei Yasuda; Masato Nakamura
Journal:  Mol Clin Oncol       Date:  2014-05-29

2.  Characterization and propagation of tumor initiating cells derived from colorectal liver metastases: trials, tribulations and a cautionary note.

Authors:  Mark I James; Lynne M Howells; Ankur Karmokar; Jennifer A Higgins; Peter Greaves; Hong Cai; Ashley Dennison; Matthew Metcalfe; Giuseppe Garcea; David M Lloyd; David P Berry; William P Steward; Karen Brown
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240

3.  Plasma membrane expression of ZNF185 is a prognostic factor in pancreatic ductal carcinoma.

Authors:  Daisuke Furukawa; Tsuyoshi Chijiwa; Masahiro Matsuyama; Masaya Mukai; Ei-Ichi Matsuo; Osamu Nishimura; Kenji Kawai; Hiroshi Suemizu; Toshio Nakagohri; Soji Ozawa; Kazuaki Shimada; Nobuyoshi Hiraoka; Masato Nakamura
Journal:  Oncol Lett       Date:  2017-07-20       Impact factor: 2.967

4.  UPLC‑MS/MS‑based metabolomic characterization and comparison of pancreatic adenocarcinoma tissues using formalin‑fixed, paraffin‑embedded and optimal cutting temperature‑embedded materials.

Authors:  Di Feng; Jing Yuan; Qi Liu; Li Liu; Xu Zhang; Yali Wu; Yifan Qian; Liping Chen; Yan Shi; Mancang Gu
Journal:  Int J Oncol       Date:  2019-10-14       Impact factor: 5.650

Review 5.  Colorectal Cancer and Purinergic Signalling: An Overview.

Authors:  Gabriela Gonçalves Roliano; Juliana Hofstätter Azambuja; Veronica Toniazzo Brunetto; Hannah Elizabeth Butterfield; Antonio Nochi Kalil; Elizandra Braganhol
Journal:  Cancers (Basel)       Date:  2022-10-06       Impact factor: 6.575

6.  Antitumor activity of melinjo (Gnetum gnemon L.) seed extract in human and murine tumor models in vitro and in a colon-26 tumor-bearing mouse model in vivo.

Authors:  Narayanan K Narayanan; Kazuhiro Kunimasa; Yukio Yamori; Mari Mori; Hideki Mori; Kazuki Nakamura; George Miller; Upender Manne; Amit K Tiwari; Bhagavathi Narayanan
Journal:  Cancer Med       Date:  2015-09-26       Impact factor: 4.452

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.